Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis-Reference-Cited by-同舟云学术

Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis

Published:2014-02-19 Issue:2 Volume:9 Page:e89230
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Amathieu Roland,Triba Mohamed N.,Nahon Pierre,Bouchemal Nadia,Kamoun Walid,Haouache Hakim,Trinchet Jean-Claude,Savarin Philippe,Le Moyec Laurence,Dhonneur Gilles

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Intensive care of the patient with cirrhosis;JC Olson;Hepatology,2011

2. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options;R Jalan;Blood purification,2002

3. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, et al.. (2013) Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144: 1426–1437, 1437 e1421–1429.

4. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL);SK Sarin;Hepatology international,2009

5. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy;WB Dunn;Chemical Society reviews,2011

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of metabolomics in liver cirrhosis and its complications;World Chinese Journal of Digestology;2024-08-28

2. Nmr Relaxation Mechanisms. Theory and Applications for Investigating Bio-Molecular Dynamics;2024

3. The metabolic fingerprint of chronic hepatitis C progression: Metabolome shifts and cutting‐edge diagnostic options;Journal of Molecular Recognition;2023-11-02

4. Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics;BMC Cardiovascular Disorders;2023-03-29

5. Screening and Validation Potential Therapeutic Marker of Early to Middle Stage ACLF Patients Treated by ALSSs;Clinical Laboratory;2023